K. Nathan Sankar

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study”.

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012

N/A

0.571DataRank · unranked

44 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2021.12.176

N/A

0.449DataRank · unranked

19 citations

K. Nathan Sankar, Garth W. Strohbehn, Lili Zhao, David J. Elliott, Victoria Daniel +3 more

de novo metastases in patients with primary colorectal cancer: a Surveillance, Epidemiology, and End Results analysis

Cancer Causes & Control(2025)10.1007/s10552-025-02002-6

N/A

0.104DataRank · unranked

1 citations

K. Nathan Sankar, Mariana C. Stern, Stephanie L. Schmit, Jane C. Figueiredo, Nicole C. Loroña

Recent advances in the management of hepatocellular carcinoma

Clinical and Molecular Hepatology(2023)10.3350/cmh.2023.0125

N/A

0DataRank · unranked

138 citations

Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen +4 more

Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma

International Journal of Molecular Sciences(2023)10.3390/ijms24087640

N/A

0DataRank · unranked

33 citations

Sang Yun Ha, Danbi Lee, K. Nathan Sankar, Ekaterina K. Koltsova, Ghassan K. Abou‐Alfa +2 more

COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States

Gastro Hep Advances(2023)10.1016/j.gastha.2023.11.011

N/A

0DataRank · unranked

6 citations

Yee Hui Yeo, Jeff Liang, Michael Luu, Walid S. Ayoub, Alexander Kuo +11 more

Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer

Lung Cancer(2021)10.1016/j.lungcan.2021.11.021

N/A

0DataRank · unranked

36 citations

K. Nathan Sankar, Garth W. Strohbehn, Lili Zhao, David J. Elliott, Angel Qin +4 more

Pre-surgery gut microbial diversity and abundance are associated with post-surgery onset of cachexia in colorectal cancer patients: the ColoCare Study

Cancer Causes & Control(2025)10.1007/s10552-025-02042-y

N/A

0DataRank · unranked

1 citations

Maria F. Gomez, Tengda Lin, Caroline Himbert, June L. Round, W. Zac Stephens +19 more

Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.03.015

N/A

0DataRank · unranked

21 citations

K. Nathan Sankar, Garth W. Strohbehn, Lili Zhao, Victoria Daniel, David J. Elliott +3 more

Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy

Cancer Cell(2023)10.1016/j.ccell.2022.12.008

N/A

0DataRank · unranked

151 citations

Jae Eun Choi, Ilona Kryczek, Yilun Sun, Peng Liao, Shasha Li +22 more